Report Detail

Medical Industry Global and United States Medically Induced Coma Market Report & Forecast 2022-2028

  • RnM4387725
  • |
  • 23 February, 2022
  • |
  • Global
  • |
  • 102 Pages
  • |
  • QYResearch
  • |
  • Medical Industry

Summary:
Medically induced coma is induced in patients with traumatic brain injury who need to cure infection. When doctors use certain drugs, they cause coma. This is an unconscious state in which the body does not feel pain. This is an effective stop of brain activity during trauma surgery.
Market Analysis and Insights: Global and United States Medically Induced Coma Market
This report focuses on global and United States Medically Induced Coma market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Medically Induced Coma market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Propofol accounting for % of the Medically Induced Coma global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospital Pharmacies was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Medically Induced Coma market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
Global Medically Induced Coma Scope and Market Size
Medically Induced Coma market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Medically Induced Coma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Medically Induced Coma market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Medically Induced Coma market is segmented into
Propofol
Barbiturate
Segment by Application, the Medically Induced Coma market is segmented into
Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Pharmacies
Regional and Country-level Analysis
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Medically Induced Coma Market Share Analysis
Medically Induced Coma market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Medically Induced Coma business, the date to enter into the Medically Induced Coma market, Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million) introduction, recent developments, etc.
The major vendors covered:
Astrazeneca
B. Braun Melsungen
Baxter Healthcare Corporation
Dr.Reddy's Laboratories
Fresenious
Hikma Pharmaceuticals
Pfizer
Piramal Healthcare
Teva Pharmaceuticals Industries
Viatris


Table of Contents

    1 Study Coverage

    • 1.1 Medically Induced Coma Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million) Introduction
    • 1.2 Global Medically Induced Coma Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Medically Induced Coma Market Size for the Year 2017-2028
      • 1.2.2 Global Medically Induced Coma Market Size for the Year 2017-2028
    • 1.3 Medically Induced Coma Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.3.1 The Market Share of United States Medically Induced Coma in Global, 2017 VS 2022 VS 2028
      • 1.3.2 The Growth Rate of Medically Induced Coma Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.4 Medically Induced Coma Market Dynamics
      • 1.4.1 Medically Induced Coma Industry Trends
      • 1.4.2 Medically Induced Coma Market Drivers
      • 1.4.3 Medically Induced Coma Market Challenges
      • 1.4.4 Medically Induced Coma Market Restraints
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Medically Induced Coma by Type

    • 2.1 Medically Induced Coma Market Segment by Type
      • 2.1.1 Propofol
      • 2.1.2 Barbiturate
    • 2.2 Global Medically Induced Coma Market Size by Type (2017, 2022 & 2028)
    • 2.3 Global Medically Induced Coma Market Size by Type (2017-2028)
    • 2.4 United States Medically Induced Coma Market Size by Type (2017, 2022 & 2028)
    • 2.5 United States Medically Induced Coma Market Size by Type (2017-2028)

    3 Medically Induced Coma by Application

    • 3.1 Medically Induced Coma Market Segment by Application
      • 3.1.1 Hospital Pharmacies
      • 3.1.2 Drug Stores & Retail Pharmacies
      • 3.1.3 Online Pharmacies
    • 3.2 Global Medically Induced Coma Market Size by Application (2017, 2022 & 2028)
    • 3.3 Global Medically Induced Coma Market Size by Application (2017-2028)
    • 3.4 United States Medically Induced Coma Market Size by Application (2017, 2022 & 2028)
    • 3.5 United States Medically Induced Coma Market Size by Application (2017-2028)

    4 Global Medically Induced Coma Competitor Landscape by Company

    • 4.1 Global Medically Induced Coma Market Size by Company
      • 4.1.1 Top Global Medically Induced Coma Companies Ranked by Revenue (2021)
      • 4.1.2 Global Medically Induced Coma Revenue by Player (2017-2022)
    • 4.2 Global Medically Induced Coma Concentration Ratio (CR)
      • 4.2.1 Medically Induced Coma Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Companies of Medically Induced Coma in 2021
      • 4.2.3 Global Medically Induced Coma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Medically Induced Coma Headquarters, Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million) Type
      • 4.3.1 Global Medically Induced Coma Headquarters and Area Served
      • 4.3.2 Global Medically Induced Coma Companies Revenue in Medically Induced Coma Business (2017-2022) & (US$ Million) Type
      • 4.3.3 Date of International Companies Enter into Medically Induced Coma Market
    • 4.4 Companies Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Medically Induced Coma Market Size by Company
      • 4.5.1 Top Medically Induced Coma Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Medically Induced Coma Revenue by Players (2020, 2021 & 2022)

    5 Global Medically Induced Coma Market Size by Region

    • 5.1 Global Medically Induced Coma Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Medically Induced Coma Market Size by Region (2017-2028)
      • 5.2.1 Global Medically Induced Coma Market Size by Region: 2017-2022
      • 5.2.2 Global Medically Induced Coma Market Size by Region (2023-2028)

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Medically Induced Coma Market Size YoY Growth 2017-2028
      • 6.1.2 North America Medically Induced Coma Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Medically Induced Coma Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Medically Induced Coma Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Medically Induced Coma Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Medically Induced Coma Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Medically Induced Coma Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Medically Induced Coma Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Medically Induced Coma Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Medically Induced Coma Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 Astrazeneca
      • 7.1.1 Astrazeneca Company Details
      • 7.1.2 Astrazeneca Business Overview
      • 7.1.3 Astrazeneca Medically Induced Coma Introduction
      • 7.1.4 Astrazeneca Revenue in Medically Induced Coma Business (2017-2022)
      • 7.1.5 Astrazeneca Recent Development
    • 7.2 B. Braun Melsungen
      • 7.2.1 B. Braun Melsungen Company Details
      • 7.2.2 B. Braun Melsungen Business Overview
      • 7.2.3 B. Braun Melsungen Medically Induced Coma Introduction
      • 7.2.4 B. Braun Melsungen Revenue in Medically Induced Coma Business (2017-2022)
      • 7.2.5 B. Braun Melsungen Recent Development
    • 7.3 Baxter Healthcare Corporation
      • 7.3.1 Baxter Healthcare Corporation Company Details
      • 7.3.2 Baxter Healthcare Corporation Business Overview
      • 7.3.3 Baxter Healthcare Corporation Medically Induced Coma Introduction
      • 7.3.4 Baxter Healthcare Corporation Revenue in Medically Induced Coma Business (2017-2022)
      • 7.3.5 Baxter Healthcare Corporation Recent Development
    • 7.4 Dr.Reddy's Laboratories
      • 7.4.1 Dr.Reddy's Laboratories Company Details
      • 7.4.2 Dr.Reddy's Laboratories Business Overview
      • 7.4.3 Dr.Reddy's Laboratories Medically Induced Coma Introduction
      • 7.4.4 Dr.Reddy's Laboratories Revenue in Medically Induced Coma Business (2017-2022)
      • 7.4.5 Dr.Reddy's Laboratories Recent Development
    • 7.5 Fresenious
      • 7.5.1 Fresenious Company Details
      • 7.5.2 Fresenious Business Overview
      • 7.5.3 Fresenious Medically Induced Coma Introduction
      • 7.5.4 Fresenious Revenue in Medically Induced Coma Business (2017-2022)
      • 7.5.5 Fresenious Recent Development
    • 7.6 Hikma Pharmaceuticals
      • 7.6.1 Hikma Pharmaceuticals Company Details
      • 7.6.2 Hikma Pharmaceuticals Business Overview
      • 7.6.3 Hikma Pharmaceuticals Medically Induced Coma Introduction
      • 7.6.4 Hikma Pharmaceuticals Revenue in Medically Induced Coma Business (2017-2022)
      • 7.6.5 Hikma Pharmaceuticals Recent Development
    • 7.7 Pfizer
      • 7.7.1 Pfizer Company Details
      • 7.7.2 Pfizer Business Overview
      • 7.7.3 Pfizer Medically Induced Coma Introduction
      • 7.7.4 Pfizer Revenue in Medically Induced Coma Business (2017-2022)
      • 7.7.5 Pfizer Recent Development
    • 7.8 Piramal Healthcare
      • 7.8.1 Piramal Healthcare Company Details
      • 7.8.2 Piramal Healthcare Business Overview
      • 7.8.3 Piramal Healthcare Medically Induced Coma Introduction
      • 7.8.4 Piramal Healthcare Revenue in Medically Induced Coma Business (2017-2022)
      • 7.8.5 Piramal Healthcare Recent Development
    • 7.9 Teva Pharmaceuticals Industries
      • 7.9.1 Teva Pharmaceuticals Industries Company Details
      • 7.9.2 Teva Pharmaceuticals Industries Business Overview
      • 7.9.3 Teva Pharmaceuticals Industries Medically Induced Coma Introduction
      • 7.9.4 Teva Pharmaceuticals Industries Revenue in Medically Induced Coma Business (2017-2022)
      • 7.9.5 Teva Pharmaceuticals Industries Recent Development
    • 7.10 Viatris
      • 7.10.1 Viatris Company Details
      • 7.10.2 Viatris Business Overview
      • 7.10.3 Viatris Medically Induced Coma Introduction
      • 7.10.4 Viatris Revenue in Medically Induced Coma Business (2017-2022)
      • 7.10.5 Viatris Recent Development

    8 Research Findings and Conclusion

      9 Appendix

      • 9.1 Research Methodology
        • 9.1.1 Methodology/Research Approach
        • 9.1.2 Data Source
      • 9.2 Author Details

      Summary:
      Get latest Market Research Reports on Medically Induced Coma. Industry analysis & Market Report on Medically Induced Coma is a syndicated market report, published as Global and United States Medically Induced Coma Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Medically Induced Coma market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,414.75
      6,829.50
      4,010.70
      8,021.40
      682,906.50
      1,365,813.00
      361,528.50
      723,057.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report